nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—ABCC1—Amprenavir—acquired immunodeficiency syndrome	0.0898	0.122	CbGbCtD
Saxagliptin—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0775	0.105	CbGbCtD
Saxagliptin—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0681	0.0924	CbGbCtD
Saxagliptin—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0681	0.0924	CbGbCtD
Saxagliptin—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.0507	0.0689	CbGbCtD
Saxagliptin—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0505	0.0685	CbGbCtD
Saxagliptin—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0368	0.05	CbGbCtD
Saxagliptin—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0333	0.0452	CbGbCtD
Saxagliptin—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0333	0.0452	CbGbCtD
Saxagliptin—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0287	0.039	CbGbCtD
Saxagliptin—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0279	0.0379	CbGbCtD
Saxagliptin—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0252	0.0343	CbGbCtD
Saxagliptin—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0252	0.0343	CbGbCtD
Saxagliptin—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0153	0.0207	CbGbCtD
Saxagliptin—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0144	0.0195	CbGbCtD
Saxagliptin—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0144	0.0195	CbGbCtD
Saxagliptin—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.013	0.0176	CbGbCtD
Saxagliptin—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.013	0.0176	CbGbCtD
Saxagliptin—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0112	0.0152	CbGbCtD
Saxagliptin—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0109	0.0148	CbGbCtD
Saxagliptin—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00984	0.0134	CbGbCtD
Saxagliptin—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00984	0.0134	CbGbCtD
Saxagliptin—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00943	0.0128	CbGbCtD
Saxagliptin—DPP4—blood plasma—acquired immunodeficiency syndrome	0.0032	0.056	CbGeAlD
Saxagliptin—DPP9—blood—acquired immunodeficiency syndrome	0.00306	0.0537	CbGeAlD
Saxagliptin—DPP8—blood—acquired immunodeficiency syndrome	0.00279	0.0489	CbGeAlD
Saxagliptin—DPP8—bone marrow—acquired immunodeficiency syndrome	0.0027	0.0473	CbGeAlD
Saxagliptin—DPP8—spinal cord—acquired immunodeficiency syndrome	0.00269	0.0471	CbGeAlD
Saxagliptin—DPP9—lung—acquired immunodeficiency syndrome	0.00269	0.0471	CbGeAlD
Saxagliptin—DPP8—vagina—acquired immunodeficiency syndrome	0.00259	0.0453	CbGeAlD
Saxagliptin—DPP8—lung—acquired immunodeficiency syndrome	0.00244	0.0428	CbGeAlD
Saxagliptin—DPP9—brain—acquired immunodeficiency syndrome	0.0019	0.0333	CbGeAlD
Saxagliptin—DPP9—lymph node—acquired immunodeficiency syndrome	0.00184	0.0322	CbGeAlD
Saxagliptin—SLCO4C1—blood—acquired immunodeficiency syndrome	0.00176	0.0309	CbGeAlD
Saxagliptin—DPP8—brain—acquired immunodeficiency syndrome	0.00173	0.0303	CbGeAlD
Saxagliptin—SLCO4C1—bone marrow—acquired immunodeficiency syndrome	0.00171	0.0299	CbGeAlD
Saxagliptin—DPP8—lymph node—acquired immunodeficiency syndrome	0.00167	0.0293	CbGeAlD
Saxagliptin—SLCO4C1—vagina—acquired immunodeficiency syndrome	0.00164	0.0287	CbGeAlD
Saxagliptin—SLCO4C1—lung—acquired immunodeficiency syndrome	0.00155	0.0271	CbGeAlD
Saxagliptin—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.00139	0.0244	CbGeAlD
Saxagliptin—DPP4—lymphoid tissue—acquired immunodeficiency syndrome	0.00124	0.0218	CbGeAlD
Saxagliptin—DPP4—digestive system—acquired immunodeficiency syndrome	0.00123	0.0215	CbGeAlD
Saxagliptin—DPP4—blood—acquired immunodeficiency syndrome	0.00117	0.0205	CbGeAlD
Saxagliptin—DPP4—bone marrow—acquired immunodeficiency syndrome	0.00113	0.0199	CbGeAlD
Saxagliptin—DPP4—vagina—acquired immunodeficiency syndrome	0.00109	0.019	CbGeAlD
Saxagliptin—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00104	0.0183	CbGeAlD
Saxagliptin—DPP4—lung—acquired immunodeficiency syndrome	0.00103	0.018	CbGeAlD
Saxagliptin—DPP4—nervous system—acquired immunodeficiency syndrome	0.000951	0.0167	CbGeAlD
Saxagliptin—DPP4—central nervous system—acquired immunodeficiency syndrome	0.000916	0.016	CbGeAlD
Saxagliptin—SLC22A8—blood—acquired immunodeficiency syndrome	0.000771	0.0135	CbGeAlD
Saxagliptin—DPP4—brain—acquired immunodeficiency syndrome	0.000727	0.0127	CbGeAlD
Saxagliptin—DPP4—lymph node—acquired immunodeficiency syndrome	0.000702	0.0123	CbGeAlD
Saxagliptin—ABCC1—blood—acquired immunodeficiency syndrome	0.000662	0.0116	CbGeAlD
Saxagliptin—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000626	0.011	CbGeAlD
Saxagliptin—ABCC1—vagina—acquired immunodeficiency syndrome	0.000614	0.0108	CbGeAlD
Saxagliptin—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000602	0.0106	CbGeAlD
Saxagliptin—ABCC1—lung—acquired immunodeficiency syndrome	0.000581	0.0102	CbGeAlD
Saxagliptin—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000534	0.00936	CbGeAlD
Saxagliptin—CYP3A5—blood—acquired immunodeficiency syndrome	0.000509	0.00892	CbGeAlD
Saxagliptin—SLC22A8—brain—acquired immunodeficiency syndrome	0.000478	0.00838	CbGeAlD
Saxagliptin—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000472	0.00827	CbGeAlD
Saxagliptin—CYP3A5—lung—acquired immunodeficiency syndrome	0.000446	0.00782	CbGeAlD
Saxagliptin—ABCC1—brain—acquired immunodeficiency syndrome	0.000411	0.0072	CbGeAlD
Saxagliptin—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000401	0.00703	CbGeAlD
Saxagliptin—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000397	0.00696	CbGeAlD
Saxagliptin—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000391	0.00189	CcSEcCtD
Saxagliptin—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000388	0.00188	CcSEcCtD
Saxagliptin—Sinusitis—Saquinavir—acquired immunodeficiency syndrome	0.000388	0.00188	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000383	0.00185	CcSEcCtD
Saxagliptin—CYP3A4—blood—acquired immunodeficiency syndrome	0.000382	0.00669	CbGeAlD
Saxagliptin—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000382	0.00185	CcSEcCtD
Saxagliptin—Oedema peripheral—Ritonavir—acquired immunodeficiency syndrome	0.00038	0.00184	CcSEcCtD
Saxagliptin—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	0.000379	0.00184	CcSEcCtD
Saxagliptin—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.000374	0.00181	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000371	0.00179	CcSEcCtD
Saxagliptin—Sinusitis—Lamivudine—acquired immunodeficiency syndrome	0.00037	0.00179	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000369	0.00179	CcSEcCtD
Saxagliptin—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000369	0.00179	CcSEcCtD
Saxagliptin—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000368	0.00178	CcSEcCtD
Saxagliptin—Myalgia—Zidovudine—acquired immunodeficiency syndrome	0.000368	0.00178	CcSEcCtD
Saxagliptin—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000368	0.00178	CcSEcCtD
Saxagliptin—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000367	0.00178	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000365	0.00177	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000364	0.00176	CcSEcCtD
Saxagliptin—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000363	0.00176	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000363	0.00176	CcSEcCtD
Saxagliptin—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000362	0.00175	CcSEcCtD
Saxagliptin—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000362	0.00175	CcSEcCtD
Saxagliptin—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000358	0.00173	CcSEcCtD
Saxagliptin—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.000358	0.00173	CcSEcCtD
Saxagliptin—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000357	0.00173	CcSEcCtD
Saxagliptin—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000352	0.00171	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000351	0.0017	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00035	0.00169	CcSEcCtD
Saxagliptin—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00035	0.00169	CcSEcCtD
Saxagliptin—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000348	0.00169	CcSEcCtD
Saxagliptin—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000347	0.00168	CcSEcCtD
Saxagliptin—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000345	0.00167	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000345	0.00167	CcSEcCtD
Saxagliptin—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000344	0.00167	CcSEcCtD
Saxagliptin—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000344	0.00167	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000343	0.00166	CcSEcCtD
Saxagliptin—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000342	0.00166	CcSEcCtD
Saxagliptin—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000342	0.00166	CcSEcCtD
Saxagliptin—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000342	0.00166	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00034	0.00164	CcSEcCtD
Saxagliptin—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000336	0.00163	CcSEcCtD
Saxagliptin—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000335	0.00162	CcSEcCtD
Saxagliptin—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000335	0.00162	CcSEcCtD
Saxagliptin—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000334	0.00162	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000333	0.00161	CcSEcCtD
Saxagliptin—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000332	0.00161	CcSEcCtD
Saxagliptin—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000332	0.00161	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000332	0.00161	CcSEcCtD
Saxagliptin—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000331	0.0016	CcSEcCtD
Saxagliptin—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00033	0.0016	CcSEcCtD
Saxagliptin—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000328	0.00159	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000327	0.00158	CcSEcCtD
Saxagliptin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000326	0.00158	CcSEcCtD
Saxagliptin—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000323	0.00156	CcSEcCtD
Saxagliptin—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000323	0.00156	CcSEcCtD
Saxagliptin—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000323	0.00156	CcSEcCtD
Saxagliptin—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000323	0.00156	CcSEcCtD
Saxagliptin—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000323	0.00156	CcSEcCtD
Saxagliptin—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000323	0.00156	CcSEcCtD
Saxagliptin—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000322	0.00156	CcSEcCtD
Saxagliptin—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000321	0.00156	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000321	0.00155	CcSEcCtD
Saxagliptin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000321	0.00155	CcSEcCtD
Saxagliptin—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000321	0.00155	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000321	0.00155	CcSEcCtD
Saxagliptin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000321	0.00155	CcSEcCtD
Saxagliptin—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00032	0.00155	CcSEcCtD
Saxagliptin—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000318	0.00154	CcSEcCtD
Saxagliptin—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000318	0.00154	CcSEcCtD
Saxagliptin—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000317	0.00154	CcSEcCtD
Saxagliptin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000316	0.00153	CcSEcCtD
Saxagliptin—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.0015	CcSEcCtD
Saxagliptin—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00031	0.00543	CbGeAlD
Saxagliptin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000309	0.0015	CcSEcCtD
Saxagliptin—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000309	0.0015	CcSEcCtD
Saxagliptin—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000309	0.0015	CcSEcCtD
Saxagliptin—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000308	0.00149	CcSEcCtD
Saxagliptin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000304	0.00147	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000304	0.00147	CcSEcCtD
Saxagliptin—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000304	0.00147	CcSEcCtD
Saxagliptin—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.00147	CcSEcCtD
Saxagliptin—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000303	0.00147	CcSEcCtD
Saxagliptin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000301	0.00146	CcSEcCtD
Saxagliptin—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000301	0.00146	CcSEcCtD
Saxagliptin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.0003	0.00145	CcSEcCtD
Saxagliptin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000299	0.00145	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000299	0.00145	CcSEcCtD
Saxagliptin—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000299	0.00523	CbGeAlD
Saxagliptin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000297	0.00144	CcSEcCtD
Saxagliptin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000297	0.00144	CcSEcCtD
Saxagliptin—Rash—Didanosine—acquired immunodeficiency syndrome	0.000294	0.00143	CcSEcCtD
Saxagliptin—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000294	0.00143	CcSEcCtD
Saxagliptin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000294	0.00142	CcSEcCtD
Saxagliptin—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000294	0.00142	CcSEcCtD
Saxagliptin—Headache—Didanosine—acquired immunodeficiency syndrome	0.000293	0.00142	CcSEcCtD
Saxagliptin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000292	0.00141	CcSEcCtD
Saxagliptin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000291	0.00141	CcSEcCtD
Saxagliptin—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00029	0.0014	CcSEcCtD
Saxagliptin—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000288	0.0014	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000288	0.0014	CcSEcCtD
Saxagliptin—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000288	0.00139	CcSEcCtD
Saxagliptin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000288	0.00139	CcSEcCtD
Saxagliptin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000287	0.00139	CcSEcCtD
Saxagliptin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000287	0.00139	CcSEcCtD
Saxagliptin—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.00138	CcSEcCtD
Saxagliptin—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.00138	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000284	0.00137	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000283	0.00137	CcSEcCtD
Saxagliptin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000283	0.00137	CcSEcCtD
Saxagliptin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000283	0.00137	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000282	0.00137	CcSEcCtD
Saxagliptin—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000282	0.00136	CcSEcCtD
Saxagliptin—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00028	0.00136	CcSEcCtD
Saxagliptin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000279	0.00135	CcSEcCtD
Saxagliptin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000277	0.00134	CcSEcCtD
Saxagliptin—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.00133	CcSEcCtD
Saxagliptin—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.00133	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000273	0.00132	CcSEcCtD
Saxagliptin—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00132	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00131	CcSEcCtD
Saxagliptin—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000269	0.0013	CcSEcCtD
Saxagliptin—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.0013	CcSEcCtD
Saxagliptin—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000268	0.0013	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000268	0.0013	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000267	0.00129	CcSEcCtD
Saxagliptin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000267	0.00129	CcSEcCtD
Saxagliptin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000267	0.00129	CcSEcCtD
Saxagliptin—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.00129	CcSEcCtD
Saxagliptin—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000265	0.00128	CcSEcCtD
Saxagliptin—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000265	0.00128	CcSEcCtD
Saxagliptin—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000264	0.00128	CcSEcCtD
Saxagliptin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000263	0.00127	CcSEcCtD
Saxagliptin—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00127	CcSEcCtD
Saxagliptin—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00127	CcSEcCtD
Saxagliptin—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.00127	CcSEcCtD
Saxagliptin—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.00126	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000261	0.00126	CcSEcCtD
Saxagliptin—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00026	0.00126	CcSEcCtD
Saxagliptin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000259	0.00125	CcSEcCtD
Saxagliptin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000259	0.00125	CcSEcCtD
Saxagliptin—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.00125	CcSEcCtD
Saxagliptin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000258	0.00125	CcSEcCtD
Saxagliptin—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000256	0.00124	CcSEcCtD
Saxagliptin—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000256	0.00124	CcSEcCtD
Saxagliptin—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.00124	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000256	0.00124	CcSEcCtD
Saxagliptin—Rash—Stavudine—acquired immunodeficiency syndrome	0.000256	0.00124	CcSEcCtD
Saxagliptin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000255	0.00124	CcSEcCtD
Saxagliptin—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000255	0.00124	CcSEcCtD
Saxagliptin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000255	0.00123	CcSEcCtD
Saxagliptin—Headache—Stavudine—acquired immunodeficiency syndrome	0.000254	0.00123	CcSEcCtD
Saxagliptin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000254	0.00123	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.00123	CcSEcCtD
Saxagliptin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000253	0.00122	CcSEcCtD
Saxagliptin—Rash—Abacavir—acquired immunodeficiency syndrome	0.000252	0.00122	CcSEcCtD
Saxagliptin—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000252	0.00122	CcSEcCtD
Saxagliptin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.00122	CcSEcCtD
Saxagliptin—Headache—Abacavir—acquired immunodeficiency syndrome	0.00025	0.00121	CcSEcCtD
Saxagliptin—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.00121	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.00121	CcSEcCtD
Saxagliptin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000249	0.00121	CcSEcCtD
Saxagliptin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000249	0.00121	CcSEcCtD
Saxagliptin—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.00119	CcSEcCtD
Saxagliptin—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000246	0.00119	CcSEcCtD
Saxagliptin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.00119	CcSEcCtD
Saxagliptin—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.00118	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.00117	CcSEcCtD
Saxagliptin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000242	0.00117	CcSEcCtD
Saxagliptin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000241	0.00117	CcSEcCtD
Saxagliptin—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00117	CcSEcCtD
Saxagliptin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000241	0.00117	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.00116	CcSEcCtD
Saxagliptin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000237	0.00115	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000237	0.00115	CcSEcCtD
Saxagliptin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000236	0.00114	CcSEcCtD
Saxagliptin—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00114	CcSEcCtD
Saxagliptin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000235	0.00114	CcSEcCtD
Saxagliptin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.00113	CcSEcCtD
Saxagliptin—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000233	0.00113	CcSEcCtD
Saxagliptin—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.00112	CcSEcCtD
Saxagliptin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000232	0.00112	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.00111	CcSEcCtD
Saxagliptin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000228	0.0011	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.0011	CcSEcCtD
Saxagliptin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.0011	CcSEcCtD
Saxagliptin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000224	0.00108	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.00108	CcSEcCtD
Saxagliptin—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000222	0.00108	CcSEcCtD
Saxagliptin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.00108	CcSEcCtD
Saxagliptin—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000222	0.00107	CcSEcCtD
Saxagliptin—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00107	CcSEcCtD
Saxagliptin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000221	0.00107	CcSEcCtD
Saxagliptin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000219	0.00106	CcSEcCtD
Saxagliptin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.00106	CcSEcCtD
Saxagliptin—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.00105	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.00105	CcSEcCtD
Saxagliptin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.00105	CcSEcCtD
Saxagliptin—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000217	0.00105	CcSEcCtD
Saxagliptin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.00105	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.00104	CcSEcCtD
Saxagliptin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.00103	CcSEcCtD
Saxagliptin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00021	0.00101	CcSEcCtD
Saxagliptin—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.00101	CcSEcCtD
Saxagliptin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000209	0.00101	CcSEcCtD
Saxagliptin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.00101	CcSEcCtD
Saxagliptin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000208	0.00101	CcSEcCtD
Saxagliptin—Rash—Indinavir—acquired immunodeficiency syndrome	0.000207	0.001	CcSEcCtD
Saxagliptin—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000206	0.001	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000996	CcSEcCtD
Saxagliptin—Headache—Indinavir—acquired immunodeficiency syndrome	0.000205	0.000994	CcSEcCtD
Saxagliptin—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000991	CcSEcCtD
Saxagliptin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000977	CcSEcCtD
Saxagliptin—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000968	CcSEcCtD
Saxagliptin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000963	CcSEcCtD
Saxagliptin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.000953	CcSEcCtD
Saxagliptin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000952	CcSEcCtD
Saxagliptin—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000949	CcSEcCtD
Saxagliptin—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.000945	CcSEcCtD
Saxagliptin—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000195	0.000944	CcSEcCtD
Saxagliptin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000943	CcSEcCtD
Saxagliptin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000941	CcSEcCtD
Saxagliptin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.000939	CcSEcCtD
Saxagliptin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000194	0.000938	CcSEcCtD
Saxagliptin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000916	CcSEcCtD
Saxagliptin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000912	CcSEcCtD
Saxagliptin—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.000904	CcSEcCtD
Saxagliptin—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.000904	CcSEcCtD
Saxagliptin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000903	CcSEcCtD
Saxagliptin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.000899	CcSEcCtD
Saxagliptin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000897	CcSEcCtD
Saxagliptin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000891	CcSEcCtD
Saxagliptin—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000877	CcSEcCtD
Saxagliptin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000874	CcSEcCtD
Saxagliptin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000862	CcSEcCtD
Saxagliptin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000852	CcSEcCtD
Saxagliptin—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000844	CcSEcCtD
Saxagliptin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000843	CcSEcCtD
Saxagliptin—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000836	CcSEcCtD
Saxagliptin—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000836	CcSEcCtD
Saxagliptin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000831	CcSEcCtD
Saxagliptin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000812	CcSEcCtD
Saxagliptin—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000805	CcSEcCtD
Saxagliptin—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000805	CcSEcCtD
Saxagliptin—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000804	CcSEcCtD
Saxagliptin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.0008	CcSEcCtD
Saxagliptin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000788	CcSEcCtD
Saxagliptin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000774	CcSEcCtD
Saxagliptin—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000768	CcSEcCtD
Saxagliptin—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000767	CcSEcCtD
Saxagliptin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000763	CcSEcCtD
Saxagliptin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000758	CcSEcCtD
Saxagliptin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000723	CcSEcCtD
